Two Sigma Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Two Sigma Securities’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,868	Closed	-$38.9K	–	3688
2022 Q4	$38.9K	Buy	43,868 +3,052	+7%	+$4.05K	0.01%	2197
2022 Q3	$64K	Hold	40,816	–	–	0.01%	2158
2022 Q2	$82K	Buy	+40,816	New	+$70.6K	0.01%	1783
2020 Q2	–	Sell	-16,709	Closed	-$31K	–	2117
2020 Q1	$31K	Buy	+16,709	New	+$48.1K	﹤0.01%	1212

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return